Search

everythinglearnresearchcommunity

for

Search:↓

Non-classical 21 hydroxylase deficiency is an underdiagnosed cause of female hair loss and polycystic ovarian syndrome.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

The 2023 guideline for PCOS suggests using updated diagnostic criteria, assessing related health risks, and recommends lifestyle changes and specific treatments for symptoms and fertility issues.

Spironolactone is a safe and effective treatment for reducing excessive hair growth in women.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Herbs can potentially treat hair loss by inhibiting a key enzyme and promoting hair growth, and deficiencies in zinc, biotin, and iron are linked to hair loss.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Women with PCOS are more likely to develop kidney stones, especially those with certain PCOS types.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

The testes produce important hormones like testosterone and others that play key roles in male body functions.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Women with irregular periods should be checked for PCOS and treated early to prevent complications, with birth control pills helping to manage symptoms.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

RE-ORGA, a Korean herb extract, may help prevent hair loss.